ESPR Live signaler | Maksimer profitt med Getagraph.com

SELG 117157 min ago

@ $2.49

Utstedt: 13 feb 2024 @ 21:31

Avkastning: -16.47%

Forrige signal: feb 12 - 19:36

Forrige signal: Kjøp

Avkastning: -4.41 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol...

Stats
Dagens volum	5.40M
Gjennomsnittsvolum	6.09M
Markedsverdi	354.47M
EPS	$0 ( 2024-02-27 )
Neste inntjeningsdato	( $-0.170 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.020
ATR14	$0.00600 (0.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-14	Warren Eric	Buy	100 000	Common Stock
2024-03-14	Warren Eric	Buy	150 000	Stock Option (right to buy)
2024-03-14	Foody Joanne M.	Buy	150 000	Common Stock
2024-03-14	Foody Joanne M.	Buy	200 000	Stock Option (right to buy)
2024-03-14	Looker Benjamin	Buy	100 000	Common Stock

INSIDER POWER
98.72
Last 98 transactions
Buy: 4 476 078 \| Sell: 52 346

Volum Korrelasjon

Lang: 0.26 (neutral)

Kort: -0.03 (neutral)

Signal:(57.265) Neutral

Esperion Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
TCPC	0.971
STIM	0.97
BRKL	0.967
RVSB	0.965
CPTN	0.964
IBCP	0.958
HMST	0.958
FNWB	0.956
FRST	0.955
ISTR	0.955

10 Mest negative korrelasjoner
ALBO	-0.958
PLPC	-0.957
MOTNU	-0.953
KBAL	-0.951
CMPI	-0.951
HUGE	-0.95
ZGNX	-0.949
ADMS	-0.949
LMB	-0.944
UNCY	-0.943

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Esperion Therapeutics Inc Korrelasjon - Valuta/Råvare

0.02
( neutral )

0.00
( neutral )

0.17
( neutral )

Esperion Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$116.33M
Bruttogevinst:	$72.90M (62.67 %)
EPS:	$-2.03

FY	2023
Omsetning:	$116.33M
Bruttogevinst:	$72.90M (62.67 %)
EPS:	$-2.03

FY	2022
Omsetning:	$75.48M
Bruttogevinst:	$48.51M (64.27 %)
EPS:	$-4.33

FY	2021
Omsetning:	$78.45M
Bruttogevinst:	$64.23M (81.88 %)
EPS:	$-10.17

Financial Reports:

No articles found.

Esperion Therapeutics Inc

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Sanntidsoppdatering for Esperion Therapeutics Inc [ESPR]

Upcoming Earnings Alert